Poxviridae Infections Drug Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Poxviridae Infections Drug in global, including the following market information:
Global Poxviridae Infections Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Poxviridae Infections Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Poxviridae Infections Drug companies in 2021 (%)
The global Poxviridae Infections Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CJ-40011 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Poxviridae Infections Drug include Bavarian Nordic A/S, BioFactura, Inc., CEL-SCI Corporation, Chimerix, Inc., China Biologic Products, Inc., CJ HealthCare Corp., EpiVax, Inc., N & N Pharmaceuticals Inc. and SIGA Technologies, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Poxviridae Infections Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Poxviridae Infections Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Poxviridae Infections Drug Market Segment Percentages, by Type, 2021 (%)
Global Poxviridae Infections Drug Market Segment Percentages, by Application, 2021 (%)
Global Poxviridae Infections Drug Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Poxviridae Infections Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Poxviridae Infections Drug revenues share in global market, 2021 (%)
Key companies Poxviridae Infections Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Poxviridae Infections Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Poxviridae Infections Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Poxviridae Infections Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Poxviridae Infections Drug companies in 2021 (%)
The global Poxviridae Infections Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CJ-40011 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Poxviridae Infections Drug include Bavarian Nordic A/S, BioFactura, Inc., CEL-SCI Corporation, Chimerix, Inc., China Biologic Products, Inc., CJ HealthCare Corp., EpiVax, Inc., N & N Pharmaceuticals Inc. and SIGA Technologies, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Poxviridae Infections Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Poxviridae Infections Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Poxviridae Infections Drug Market Segment Percentages, by Type, 2021 (%)
- CJ-40011
- 24a
- BA-368
- Others
Global Poxviridae Infections Drug Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinic
- Others
Global Poxviridae Infections Drug Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Poxviridae Infections Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Poxviridae Infections Drug revenues share in global market, 2021 (%)
Key companies Poxviridae Infections Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Poxviridae Infections Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bavarian Nordic A/S
- BioFactura, Inc.
- CEL-SCI Corporation
- Chimerix, Inc.
- China Biologic Products, Inc.
- CJ HealthCare Corp.
- EpiVax, Inc.
- N & N Pharmaceuticals Inc.
- SIGA Technologies, Inc.
- Takeda Pharmaceutical Company Limited
- Tonix Pharmaceuticals Holding Corp.
- Verrica Pharmaceuticals Inc.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Poxviridae Infections Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Poxviridae Infections Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL POXVIRIDAE INFECTIONS DRUG OVERALL MARKET SIZE
2.1 Global Poxviridae Infections Drug Market Size: 2021 VS 2028
2.2 Global Poxviridae Infections Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Poxviridae Infections Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Poxviridae Infections Drug Players in Global Market
3.2 Top Global Poxviridae Infections Drug Companies Ranked by Revenue
3.3 Global Poxviridae Infections Drug Revenue by Companies
3.4 Global Poxviridae Infections Drug Sales by Companies
3.5 Global Poxviridae Infections Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Poxviridae Infections Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Poxviridae Infections Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Poxviridae Infections Drug Players in Global Market
3.8.1 List of Global Tier 1 Poxviridae Infections Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Poxviridae Infections Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Poxviridae Infections Drug Market Size Markets, 2021 & 2028
4.1.2 CJ-40011
4.1.3 24a
4.1.4 BA-368
4.1.5 Others
4.2 By Type - Global Poxviridae Infections Drug Revenue & Forecasts
4.2.1 By Type - Global Poxviridae Infections Drug Revenue, 2017-2022
4.2.2 By Type - Global Poxviridae Infections Drug Revenue, 2023-2028
4.2.3 By Type - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Poxviridae Infections Drug Sales & Forecasts
4.3.1 By Type - Global Poxviridae Infections Drug Sales, 2017-2022
4.3.2 By Type - Global Poxviridae Infections Drug Sales, 2023-2028
4.3.3 By Type - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
4.4 By Type - Global Poxviridae Infections Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Poxviridae Infections Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Poxviridae Infections Drug Revenue & Forecasts
5.2.1 By Application - Global Poxviridae Infections Drug Revenue, 2017-2022
5.2.2 By Application - Global Poxviridae Infections Drug Revenue, 2023-2028
5.2.3 By Application - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Poxviridae Infections Drug Sales & Forecasts
5.3.1 By Application - Global Poxviridae Infections Drug Sales, 2017-2022
5.3.2 By Application - Global Poxviridae Infections Drug Sales, 2023-2028
5.3.3 By Application - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
5.4 By Application - Global Poxviridae Infections Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Poxviridae Infections Drug Market Size, 2021 & 2028
6.2 By Region - Global Poxviridae Infections Drug Revenue & Forecasts
6.2.1 By Region - Global Poxviridae Infections Drug Revenue, 2017-2022
6.2.2 By Region - Global Poxviridae Infections Drug Revenue, 2023-2028
6.2.3 By Region - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Poxviridae Infections Drug Sales & Forecasts
6.3.1 By Region - Global Poxviridae Infections Drug Sales, 2017-2022
6.3.2 By Region - Global Poxviridae Infections Drug Sales, 2023-2028
6.3.3 By Region - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Poxviridae Infections Drug Revenue, 2017-2028
6.4.2 By Country - North America Poxviridae Infections Drug Sales, 2017-2028
6.4.3 US Poxviridae Infections Drug Market Size, 2017-2028
6.4.4 Canada Poxviridae Infections Drug Market Size, 2017-2028
6.4.5 Mexico Poxviridae Infections Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Poxviridae Infections Drug Revenue, 2017-2028
6.5.2 By Country - Europe Poxviridae Infections Drug Sales, 2017-2028
6.5.3 Germany Poxviridae Infections Drug Market Size, 2017-2028
6.5.4 France Poxviridae Infections Drug Market Size, 2017-2028
6.5.5 U.K. Poxviridae Infections Drug Market Size, 2017-2028
6.5.6 Italy Poxviridae Infections Drug Market Size, 2017-2028
6.5.7 Russia Poxviridae Infections Drug Market Size, 2017-2028
6.5.8 Nordic Countries Poxviridae Infections Drug Market Size, 2017-2028
6.5.9 Benelux Poxviridae Infections Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Poxviridae Infections Drug Revenue, 2017-2028
6.6.2 By Region - Asia Poxviridae Infections Drug Sales, 2017-2028
6.6.3 China Poxviridae Infections Drug Market Size, 2017-2028
6.6.4 Japan Poxviridae Infections Drug Market Size, 2017-2028
6.6.5 South Korea Poxviridae Infections Drug Market Size, 2017-2028
6.6.6 Southeast Asia Poxviridae Infections Drug Market Size, 2017-2028
6.6.7 India Poxviridae Infections Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Poxviridae Infections Drug Revenue, 2017-2028
6.7.2 By Country - South America Poxviridae Infections Drug Sales, 2017-2028
6.7.3 Brazil Poxviridae Infections Drug Market Size, 2017-2028
6.7.4 Argentina Poxviridae Infections Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Poxviridae Infections Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Poxviridae Infections Drug Sales, 2017-2028
6.8.3 Turkey Poxviridae Infections Drug Market Size, 2017-2028
6.8.4 Israel Poxviridae Infections Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Poxviridae Infections Drug Market Size, 2017-2028
6.8.6 UAE Poxviridae Infections Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bavarian Nordic A/S
7.1.1 Bavarian Nordic A/S Corporate Summary
7.1.2 Bavarian Nordic A/S Business Overview
7.1.3 Bavarian Nordic A/S Poxviridae Infections Drug Major Product Offerings
7.1.4 Bavarian Nordic A/S Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.1.5 Bavarian Nordic A/S Key News
7.2 BioFactura, Inc.
7.2.1 BioFactura, Inc. Corporate Summary
7.2.2 BioFactura, Inc. Business Overview
7.2.3 BioFactura, Inc. Poxviridae Infections Drug Major Product Offerings
7.2.4 BioFactura, Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.2.5 BioFactura, Inc. Key News
7.3 CEL-SCI Corporation
7.3.1 CEL-SCI Corporation Corporate Summary
7.3.2 CEL-SCI Corporation Business Overview
7.3.3 CEL-SCI Corporation Poxviridae Infections Drug Major Product Offerings
7.3.4 CEL-SCI Corporation Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.3.5 CEL-SCI Corporation Key News
7.4 Chimerix, Inc.
7.4.1 Chimerix, Inc. Corporate Summary
7.4.2 Chimerix, Inc. Business Overview
7.4.3 Chimerix, Inc. Poxviridae Infections Drug Major Product Offerings
7.4.4 Chimerix, Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.4.5 Chimerix, Inc. Key News
7.5 China Biologic Products, Inc.
7.5.1 China Biologic Products, Inc. Corporate Summary
7.5.2 China Biologic Products, Inc. Business Overview
7.5.3 China Biologic Products, Inc. Poxviridae Infections Drug Major Product Offerings
7.5.4 China Biologic Products, Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.5.5 China Biologic Products, Inc. Key News
7.6 CJ HealthCare Corp.
7.6.1 CJ HealthCare Corp. Corporate Summary
7.6.2 CJ HealthCare Corp. Business Overview
7.6.3 CJ HealthCare Corp. Poxviridae Infections Drug Major Product Offerings
7.6.4 CJ HealthCare Corp. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.6.5 CJ HealthCare Corp. Key News
7.7 EpiVax, Inc.
7.7.1 EpiVax, Inc. Corporate Summary
7.7.2 EpiVax, Inc. Business Overview
7.7.3 EpiVax, Inc. Poxviridae Infections Drug Major Product Offerings
7.7.4 EpiVax, Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.7.5 EpiVax, Inc. Key News
7.8 N & N Pharmaceuticals Inc.
7.8.1 N & N Pharmaceuticals Inc. Corporate Summary
7.8.2 N & N Pharmaceuticals Inc. Business Overview
7.8.3 N & N Pharmaceuticals Inc. Poxviridae Infections Drug Major Product Offerings
7.8.4 N & N Pharmaceuticals Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.8.5 N & N Pharmaceuticals Inc. Key News
7.9 SIGA Technologies, Inc.
7.9.1 SIGA Technologies, Inc. Corporate Summary
7.9.2 SIGA Technologies, Inc. Business Overview
7.9.3 SIGA Technologies, Inc. Poxviridae Infections Drug Major Product Offerings
7.9.4 SIGA Technologies, Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.9.5 SIGA Technologies, Inc. Key News
7.10 Takeda Pharmaceutical Company Limited
7.10.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.10.2 Takeda Pharmaceutical Company Limited Business Overview
7.10.3 Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Major Product Offerings
7.10.4 Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.10.5 Takeda Pharmaceutical Company Limited Key News
7.11 Tonix Pharmaceuticals Holding Corp.
7.11.1 Tonix Pharmaceuticals Holding Corp. Corporate Summary
7.11.2 Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Business Overview
7.11.3 Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Major Product Offerings
7.11.4 Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.11.5 Tonix Pharmaceuticals Holding Corp. Key News
7.12 Verrica Pharmaceuticals Inc.
7.12.1 Verrica Pharmaceuticals Inc. Corporate Summary
7.12.2 Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Business Overview
7.12.3 Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Major Product Offerings
7.12.4 Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.12.5 Verrica Pharmaceuticals Inc. Key News
8 GLOBAL POXVIRIDAE INFECTIONS DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global Poxviridae Infections Drug Production Capacity, 2017-2028
8.2 Poxviridae Infections Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Poxviridae Infections Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 POXVIRIDAE INFECTIONS DRUG SUPPLY CHAIN ANALYSIS
10.1 Poxviridae Infections Drug Industry Value Chain
10.2 Poxviridae Infections Drug Upstream Market
10.3 Poxviridae Infections Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Poxviridae Infections Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Poxviridae Infections Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Poxviridae Infections Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL POXVIRIDAE INFECTIONS DRUG OVERALL MARKET SIZE
2.1 Global Poxviridae Infections Drug Market Size: 2021 VS 2028
2.2 Global Poxviridae Infections Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Poxviridae Infections Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Poxviridae Infections Drug Players in Global Market
3.2 Top Global Poxviridae Infections Drug Companies Ranked by Revenue
3.3 Global Poxviridae Infections Drug Revenue by Companies
3.4 Global Poxviridae Infections Drug Sales by Companies
3.5 Global Poxviridae Infections Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Poxviridae Infections Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Poxviridae Infections Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Poxviridae Infections Drug Players in Global Market
3.8.1 List of Global Tier 1 Poxviridae Infections Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Poxviridae Infections Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Poxviridae Infections Drug Market Size Markets, 2021 & 2028
4.1.2 CJ-40011
4.1.3 24a
4.1.4 BA-368
4.1.5 Others
4.2 By Type - Global Poxviridae Infections Drug Revenue & Forecasts
4.2.1 By Type - Global Poxviridae Infections Drug Revenue, 2017-2022
4.2.2 By Type - Global Poxviridae Infections Drug Revenue, 2023-2028
4.2.3 By Type - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Poxviridae Infections Drug Sales & Forecasts
4.3.1 By Type - Global Poxviridae Infections Drug Sales, 2017-2022
4.3.2 By Type - Global Poxviridae Infections Drug Sales, 2023-2028
4.3.3 By Type - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
4.4 By Type - Global Poxviridae Infections Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Poxviridae Infections Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Poxviridae Infections Drug Revenue & Forecasts
5.2.1 By Application - Global Poxviridae Infections Drug Revenue, 2017-2022
5.2.2 By Application - Global Poxviridae Infections Drug Revenue, 2023-2028
5.2.3 By Application - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Poxviridae Infections Drug Sales & Forecasts
5.3.1 By Application - Global Poxviridae Infections Drug Sales, 2017-2022
5.3.2 By Application - Global Poxviridae Infections Drug Sales, 2023-2028
5.3.3 By Application - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
5.4 By Application - Global Poxviridae Infections Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Poxviridae Infections Drug Market Size, 2021 & 2028
6.2 By Region - Global Poxviridae Infections Drug Revenue & Forecasts
6.2.1 By Region - Global Poxviridae Infections Drug Revenue, 2017-2022
6.2.2 By Region - Global Poxviridae Infections Drug Revenue, 2023-2028
6.2.3 By Region - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Poxviridae Infections Drug Sales & Forecasts
6.3.1 By Region - Global Poxviridae Infections Drug Sales, 2017-2022
6.3.2 By Region - Global Poxviridae Infections Drug Sales, 2023-2028
6.3.3 By Region - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Poxviridae Infections Drug Revenue, 2017-2028
6.4.2 By Country - North America Poxviridae Infections Drug Sales, 2017-2028
6.4.3 US Poxviridae Infections Drug Market Size, 2017-2028
6.4.4 Canada Poxviridae Infections Drug Market Size, 2017-2028
6.4.5 Mexico Poxviridae Infections Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Poxviridae Infections Drug Revenue, 2017-2028
6.5.2 By Country - Europe Poxviridae Infections Drug Sales, 2017-2028
6.5.3 Germany Poxviridae Infections Drug Market Size, 2017-2028
6.5.4 France Poxviridae Infections Drug Market Size, 2017-2028
6.5.5 U.K. Poxviridae Infections Drug Market Size, 2017-2028
6.5.6 Italy Poxviridae Infections Drug Market Size, 2017-2028
6.5.7 Russia Poxviridae Infections Drug Market Size, 2017-2028
6.5.8 Nordic Countries Poxviridae Infections Drug Market Size, 2017-2028
6.5.9 Benelux Poxviridae Infections Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Poxviridae Infections Drug Revenue, 2017-2028
6.6.2 By Region - Asia Poxviridae Infections Drug Sales, 2017-2028
6.6.3 China Poxviridae Infections Drug Market Size, 2017-2028
6.6.4 Japan Poxviridae Infections Drug Market Size, 2017-2028
6.6.5 South Korea Poxviridae Infections Drug Market Size, 2017-2028
6.6.6 Southeast Asia Poxviridae Infections Drug Market Size, 2017-2028
6.6.7 India Poxviridae Infections Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Poxviridae Infections Drug Revenue, 2017-2028
6.7.2 By Country - South America Poxviridae Infections Drug Sales, 2017-2028
6.7.3 Brazil Poxviridae Infections Drug Market Size, 2017-2028
6.7.4 Argentina Poxviridae Infections Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Poxviridae Infections Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Poxviridae Infections Drug Sales, 2017-2028
6.8.3 Turkey Poxviridae Infections Drug Market Size, 2017-2028
6.8.4 Israel Poxviridae Infections Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Poxviridae Infections Drug Market Size, 2017-2028
6.8.6 UAE Poxviridae Infections Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bavarian Nordic A/S
7.1.1 Bavarian Nordic A/S Corporate Summary
7.1.2 Bavarian Nordic A/S Business Overview
7.1.3 Bavarian Nordic A/S Poxviridae Infections Drug Major Product Offerings
7.1.4 Bavarian Nordic A/S Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.1.5 Bavarian Nordic A/S Key News
7.2 BioFactura, Inc.
7.2.1 BioFactura, Inc. Corporate Summary
7.2.2 BioFactura, Inc. Business Overview
7.2.3 BioFactura, Inc. Poxviridae Infections Drug Major Product Offerings
7.2.4 BioFactura, Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.2.5 BioFactura, Inc. Key News
7.3 CEL-SCI Corporation
7.3.1 CEL-SCI Corporation Corporate Summary
7.3.2 CEL-SCI Corporation Business Overview
7.3.3 CEL-SCI Corporation Poxviridae Infections Drug Major Product Offerings
7.3.4 CEL-SCI Corporation Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.3.5 CEL-SCI Corporation Key News
7.4 Chimerix, Inc.
7.4.1 Chimerix, Inc. Corporate Summary
7.4.2 Chimerix, Inc. Business Overview
7.4.3 Chimerix, Inc. Poxviridae Infections Drug Major Product Offerings
7.4.4 Chimerix, Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.4.5 Chimerix, Inc. Key News
7.5 China Biologic Products, Inc.
7.5.1 China Biologic Products, Inc. Corporate Summary
7.5.2 China Biologic Products, Inc. Business Overview
7.5.3 China Biologic Products, Inc. Poxviridae Infections Drug Major Product Offerings
7.5.4 China Biologic Products, Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.5.5 China Biologic Products, Inc. Key News
7.6 CJ HealthCare Corp.
7.6.1 CJ HealthCare Corp. Corporate Summary
7.6.2 CJ HealthCare Corp. Business Overview
7.6.3 CJ HealthCare Corp. Poxviridae Infections Drug Major Product Offerings
7.6.4 CJ HealthCare Corp. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.6.5 CJ HealthCare Corp. Key News
7.7 EpiVax, Inc.
7.7.1 EpiVax, Inc. Corporate Summary
7.7.2 EpiVax, Inc. Business Overview
7.7.3 EpiVax, Inc. Poxviridae Infections Drug Major Product Offerings
7.7.4 EpiVax, Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.7.5 EpiVax, Inc. Key News
7.8 N & N Pharmaceuticals Inc.
7.8.1 N & N Pharmaceuticals Inc. Corporate Summary
7.8.2 N & N Pharmaceuticals Inc. Business Overview
7.8.3 N & N Pharmaceuticals Inc. Poxviridae Infections Drug Major Product Offerings
7.8.4 N & N Pharmaceuticals Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.8.5 N & N Pharmaceuticals Inc. Key News
7.9 SIGA Technologies, Inc.
7.9.1 SIGA Technologies, Inc. Corporate Summary
7.9.2 SIGA Technologies, Inc. Business Overview
7.9.3 SIGA Technologies, Inc. Poxviridae Infections Drug Major Product Offerings
7.9.4 SIGA Technologies, Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.9.5 SIGA Technologies, Inc. Key News
7.10 Takeda Pharmaceutical Company Limited
7.10.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.10.2 Takeda Pharmaceutical Company Limited Business Overview
7.10.3 Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Major Product Offerings
7.10.4 Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.10.5 Takeda Pharmaceutical Company Limited Key News
7.11 Tonix Pharmaceuticals Holding Corp.
7.11.1 Tonix Pharmaceuticals Holding Corp. Corporate Summary
7.11.2 Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Business Overview
7.11.3 Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Major Product Offerings
7.11.4 Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.11.5 Tonix Pharmaceuticals Holding Corp. Key News
7.12 Verrica Pharmaceuticals Inc.
7.12.1 Verrica Pharmaceuticals Inc. Corporate Summary
7.12.2 Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Business Overview
7.12.3 Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Major Product Offerings
7.12.4 Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Sales and Revenue in Global (2017-2022)
7.12.5 Verrica Pharmaceuticals Inc. Key News
8 GLOBAL POXVIRIDAE INFECTIONS DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global Poxviridae Infections Drug Production Capacity, 2017-2028
8.2 Poxviridae Infections Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Poxviridae Infections Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 POXVIRIDAE INFECTIONS DRUG SUPPLY CHAIN ANALYSIS
10.1 Poxviridae Infections Drug Industry Value Chain
10.2 Poxviridae Infections Drug Upstream Market
10.3 Poxviridae Infections Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Poxviridae Infections Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Poxviridae Infections Drug in Global Market
Table 2. Top Poxviridae Infections Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Poxviridae Infections Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Poxviridae Infections Drug Revenue Share by Companies, 2017-2022
Table 5. Global Poxviridae Infections Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Poxviridae Infections Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Poxviridae Infections Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Poxviridae Infections Drug Product Type
Table 9. List of Global Tier 1 Poxviridae Infections Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Poxviridae Infections Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Poxviridae Infections Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Poxviridae Infections Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Poxviridae Infections Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Poxviridae Infections Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Poxviridae Infections Drug Sales (K Pcs), 2023-2028
Table 16. By Application – Global Poxviridae Infections Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Poxviridae Infections Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Poxviridae Infections Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Poxviridae Infections Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Poxviridae Infections Drug Sales (K Pcs), 2023-2028
Table 21. By Region – Global Poxviridae Infections Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Poxviridae Infections Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Poxviridae Infections Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Poxviridae Infections Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Poxviridae Infections Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Poxviridae Infections Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Poxviridae Infections Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Poxviridae Infections Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Poxviridae Infections Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Poxviridae Infections Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Poxviridae Infections Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Poxviridae Infections Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Poxviridae Infections Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Poxviridae Infections Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Poxviridae Infections Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Poxviridae Infections Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Poxviridae Infections Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Poxviridae Infections Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Poxviridae Infections Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Poxviridae Infections Drug Sales, (K Pcs), 2023-2028
Table 46. Bavarian Nordic A/S Corporate Summary
Table 47. Bavarian Nordic A/S Poxviridae Infections Drug Product Offerings
Table 48. Bavarian Nordic A/S Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. BioFactura, Inc. Corporate Summary
Table 50. BioFactura, Inc. Poxviridae Infections Drug Product Offerings
Table 51. BioFactura, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. CEL-SCI Corporation Corporate Summary
Table 53. CEL-SCI Corporation Poxviridae Infections Drug Product Offerings
Table 54. CEL-SCI Corporation Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Chimerix, Inc. Corporate Summary
Table 56. Chimerix, Inc. Poxviridae Infections Drug Product Offerings
Table 57. Chimerix, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. China Biologic Products, Inc. Corporate Summary
Table 59. China Biologic Products, Inc. Poxviridae Infections Drug Product Offerings
Table 60. China Biologic Products, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. CJ HealthCare Corp. Corporate Summary
Table 62. CJ HealthCare Corp. Poxviridae Infections Drug Product Offerings
Table 63. CJ HealthCare Corp. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. EpiVax, Inc. Corporate Summary
Table 65. EpiVax, Inc. Poxviridae Infections Drug Product Offerings
Table 66. EpiVax, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. N & N Pharmaceuticals Inc. Corporate Summary
Table 68. N & N Pharmaceuticals Inc. Poxviridae Infections Drug Product Offerings
Table 69. N & N Pharmaceuticals Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. SIGA Technologies, Inc. Corporate Summary
Table 71. SIGA Technologies, Inc. Poxviridae Infections Drug Product Offerings
Table 72. SIGA Technologies, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Takeda Pharmaceutical Company Limited Corporate Summary
Table 74. Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Product Offerings
Table 75. Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Tonix Pharmaceuticals Holding Corp. Corporate Summary
Table 77. Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Product Offerings
Table 78. Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Verrica Pharmaceuticals Inc. Corporate Summary
Table 80. Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Product Offerings
Table 81. Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Poxviridae Infections Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 83. Global Poxviridae Infections Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Poxviridae Infections Drug Production by Region, 2017-2022 (K Pcs)
Table 85. Global Poxviridae Infections Drug Production by Region, 2023-2028 (K Pcs)
Table 86. Poxviridae Infections Drug Market Opportunities & Trends in Global Market
Table 87. Poxviridae Infections Drug Market Drivers in Global Market
Table 88. Poxviridae Infections Drug Market Restraints in Global Market
Table 89. Poxviridae Infections Drug Raw Materials
Table 90. Poxviridae Infections Drug Raw Materials Suppliers in Global Market
Table 91. Typical Poxviridae Infections Drug Downstream
Table 92. Poxviridae Infections Drug Downstream Clients in Global Market
Table 93. Poxviridae Infections Drug Distributors and Sales Agents in Global Market
Table 1. Key Players of Poxviridae Infections Drug in Global Market
Table 2. Top Poxviridae Infections Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Poxviridae Infections Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Poxviridae Infections Drug Revenue Share by Companies, 2017-2022
Table 5. Global Poxviridae Infections Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Poxviridae Infections Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Poxviridae Infections Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Poxviridae Infections Drug Product Type
Table 9. List of Global Tier 1 Poxviridae Infections Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Poxviridae Infections Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Poxviridae Infections Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Poxviridae Infections Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Poxviridae Infections Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Poxviridae Infections Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Poxviridae Infections Drug Sales (K Pcs), 2023-2028
Table 16. By Application – Global Poxviridae Infections Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Poxviridae Infections Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Poxviridae Infections Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Poxviridae Infections Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Poxviridae Infections Drug Sales (K Pcs), 2023-2028
Table 21. By Region – Global Poxviridae Infections Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Poxviridae Infections Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Poxviridae Infections Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Poxviridae Infections Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Poxviridae Infections Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Poxviridae Infections Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Poxviridae Infections Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Poxviridae Infections Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Poxviridae Infections Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Poxviridae Infections Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Poxviridae Infections Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Poxviridae Infections Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Poxviridae Infections Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Poxviridae Infections Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Poxviridae Infections Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Poxviridae Infections Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Poxviridae Infections Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Poxviridae Infections Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Poxviridae Infections Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Poxviridae Infections Drug Sales, (K Pcs), 2023-2028
Table 46. Bavarian Nordic A/S Corporate Summary
Table 47. Bavarian Nordic A/S Poxviridae Infections Drug Product Offerings
Table 48. Bavarian Nordic A/S Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. BioFactura, Inc. Corporate Summary
Table 50. BioFactura, Inc. Poxviridae Infections Drug Product Offerings
Table 51. BioFactura, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. CEL-SCI Corporation Corporate Summary
Table 53. CEL-SCI Corporation Poxviridae Infections Drug Product Offerings
Table 54. CEL-SCI Corporation Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Chimerix, Inc. Corporate Summary
Table 56. Chimerix, Inc. Poxviridae Infections Drug Product Offerings
Table 57. Chimerix, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. China Biologic Products, Inc. Corporate Summary
Table 59. China Biologic Products, Inc. Poxviridae Infections Drug Product Offerings
Table 60. China Biologic Products, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. CJ HealthCare Corp. Corporate Summary
Table 62. CJ HealthCare Corp. Poxviridae Infections Drug Product Offerings
Table 63. CJ HealthCare Corp. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. EpiVax, Inc. Corporate Summary
Table 65. EpiVax, Inc. Poxviridae Infections Drug Product Offerings
Table 66. EpiVax, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. N & N Pharmaceuticals Inc. Corporate Summary
Table 68. N & N Pharmaceuticals Inc. Poxviridae Infections Drug Product Offerings
Table 69. N & N Pharmaceuticals Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. SIGA Technologies, Inc. Corporate Summary
Table 71. SIGA Technologies, Inc. Poxviridae Infections Drug Product Offerings
Table 72. SIGA Technologies, Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Takeda Pharmaceutical Company Limited Corporate Summary
Table 74. Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Product Offerings
Table 75. Takeda Pharmaceutical Company Limited Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Tonix Pharmaceuticals Holding Corp. Corporate Summary
Table 77. Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Product Offerings
Table 78. Tonix Pharmaceuticals Holding Corp. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Verrica Pharmaceuticals Inc. Corporate Summary
Table 80. Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Product Offerings
Table 81. Verrica Pharmaceuticals Inc. Poxviridae Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Poxviridae Infections Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 83. Global Poxviridae Infections Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Poxviridae Infections Drug Production by Region, 2017-2022 (K Pcs)
Table 85. Global Poxviridae Infections Drug Production by Region, 2023-2028 (K Pcs)
Table 86. Poxviridae Infections Drug Market Opportunities & Trends in Global Market
Table 87. Poxviridae Infections Drug Market Drivers in Global Market
Table 88. Poxviridae Infections Drug Market Restraints in Global Market
Table 89. Poxviridae Infections Drug Raw Materials
Table 90. Poxviridae Infections Drug Raw Materials Suppliers in Global Market
Table 91. Typical Poxviridae Infections Drug Downstream
Table 92. Poxviridae Infections Drug Downstream Clients in Global Market
Table 93. Poxviridae Infections Drug Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Poxviridae Infections Drug Segment by Type
Figure 2. Poxviridae Infections Drug Segment by Application
Figure 3. Global Poxviridae Infections Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Poxviridae Infections Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Poxviridae Infections Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Poxviridae Infections Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Poxviridae Infections Drug Revenue in 2021
Figure 9. By Type - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Poxviridae Infections Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Poxviridae Infections Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 19. US Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 24. Germany Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 33. China Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 40. Brazil Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 44. Turkey Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Poxviridae Infections Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Poxviridae Infections Drug by Region, 2021 VS 2028
Figure 50. Poxviridae Infections Drug Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Poxviridae Infections Drug Segment by Type
Figure 2. Poxviridae Infections Drug Segment by Application
Figure 3. Global Poxviridae Infections Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Poxviridae Infections Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Poxviridae Infections Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Poxviridae Infections Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Poxviridae Infections Drug Revenue in 2021
Figure 9. By Type - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Poxviridae Infections Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Poxviridae Infections Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 19. US Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 24. Germany Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 33. China Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 40. Brazil Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Poxviridae Infections Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Poxviridae Infections Drug Sales Market Share, 2017-2028
Figure 44. Turkey Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Poxviridae Infections Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Poxviridae Infections Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Poxviridae Infections Drug by Region, 2021 VS 2028
Figure 50. Poxviridae Infections Drug Industry Value Chain
Figure 51. Marketing Channels
